Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

15 Jan 2018 07:00

RNS Number : 8071B
TyraTech, Inc.
15 January 2018
 

For immediate release: 15th January 2018

The following announcement replaces that which was released on 5 January 2018 at 7:00am RNS number 0361B.

The previous announcement included the Company's 1,084,413 Common Shares which are held in Treasury when calculating the denominator to be used by Shareholders. For consistency with the previous convention adopted by the Company, the reference to "162,672,054" as the denominator should have been "161,587,641". The full amended text appears below.

TYRATECH, INC.

 

("TyraTech" or the "Company")

Result of Tender Offer

 

TyraTech Inc. (AIM: TYR, and TYRU), the life sciences company focused on nature-derived insect and parasite control products, is pleased to announce the results of the Tender Offer, details of which were set out in the shareholder circular published by the Company on 4 December 2017.

Result of Tender Offer

Under the Tender Offer 204,994,390 Common Shares were validly tendered and will be purchased at a price per Common Share of 3 pence, for an aggregate purchase price of $8.4 million. The Common Shares purchased under the Tender Offer represent approximately 55.8 per cent. of the Company's Issued Capital.

It is anticipated that the proceeds payable under the Tender Offer to the Company's Shareholders who hold their Shares in certificated form will be despatched on 15 January 2018 in the form of a cheque. Those Shareholders who hold their Shares in uncertificated form will have their CREST accounts credited on 8 January 2018.

The Company intends to retire the Common Shares purchased by it under the Tender Offer, reducing the number of issued and outstanding Shares from 367,666,444 Shares to 162,672,054 Common Shares. The Company has 1,084,413 Common Shares held in Treasury.

It is anticipated that retirement of the shares will occur on 8 January 2018 and after this time Shareholders may use 161,587,641 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

Directors' Interests

Number of Shares prior to the Tender Offer

Percentage of issued capital (voting rights) prior to the Tender Offer

Number of Shares sold under the Tender Offer

Number of Shares following the Tender Offer

Percentage of issued capital (voting rights) following retirement of the Tender Offer shares

James Hills

3,029,957

0.83%

nil

3,029,957

1.88%

Bruno Jactel

2,438,157

0.67%

nil

2,438,157

1.51%

Barrington Marshall Riley

3,723,413

1.02%

nil

3,723,413

2.30%

 

-ends-

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meaning as defined in the Circular.

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information:

 

TyraTech Inc.

Bruno Jactel, Chief Executive Officer

Erica H. Boisvert, Chief Financial Officer

www.tyratech.com

 

Tel: +1 919 415 4340

Tel: +1 919 415 4287

 

SPARK Advisory Partners Limited (Nominated Adviser)

Matt Davis / Mark Brady

 

 

 Tel: +44 20 3368 3552

 

Allenby Capital Limited (Broker)

Chris Crawford

 

 

Tel: +44 20 3328 5656

 

 

Belvedere Communications (PR)

John West / Kim van Beeck

 Tel: +44 20 3567 0510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RTEBLGDBCUBBGIS
Date   Source Headline
17th Dec 20154:01 pmRNSTR-1: Notification of Major Interest in Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
26th Nov 201512:51 pmRNSTR-1: Notification of Major Interest in Shares
16th Nov 20155:01 pmRNSResult of Special Meeting & Director Shareholdings
4th Nov 20157:00 amRNSPlacing and Subscription to raise £3.16m
24th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20157:00 amRNSMigration of shares
6th Aug 20157:00 amRNSMigration of Shares
30th Jul 20154:38 pmRNSResult of AGM
3rd Jul 20155:04 pmRNSMigration of Shares
22nd Jun 20157:00 amRNSFinal Results
10th Jun 20152:22 pmRNSMigration of Shares
21st May 20155:45 pmRNSMigration of Shares
22nd Apr 20157:00 amRNSDirector's Dealings
20th Apr 20157:00 amRNSEnvance LLC amended: Sharpened strategic focus
9th Apr 20151:14 pmRNSMigration of Shares
8th Apr 20157:00 amRNSListing with Walgreens in the USA
27th Mar 20159:41 amRNSMigration of Shares and Exercise of SARs
25th Mar 20157:00 amRNSVamousse now distributed by CVS in the USA
3rd Mar 20157:00 amRNSVamousse now listed by the top 3 distributors, USA
25th Feb 20157:00 amRNSLloyds and Day Lewis Pharmacy listings
16th Feb 20155:01 pmRNSDirector's Dealings
2nd Feb 20157:00 amRNSVamousse at Walmart and Cardinal Health USA
15th Jan 20157:00 amRNSAppointment of Chief Financial Officer & Treasurer
2nd Dec 20147:00 amRNSTrading Update
1st Oct 20147:00 amRNSExercise of Warrants
29th Sep 20147:00 amRNSInterim Results
27th Aug 20147:00 amRNSVamousse products coming to Sainsbury's and Tesco
8th Aug 201410:30 amRNSHolding(s) in Company
5th Aug 201410:29 amRNSHolding(s) in Company
1st Aug 20145:49 pmRNSHolding(s) in Company
1st Aug 20142:40 pmRNSHolding(s) in Company
28th Jul 20145:35 pmRNSResult of Special Meeting & Director Shareholdings
16th Jul 20147:00 amRNSResult of AGM
16th Jul 20147:00 amRNSPlacing to raise £3.5m and launch of UK Vamousse
26th Jun 20147:00 amRNSFinal Results
22nd May 20144:02 pmRNSMigration of Shares
19th May 20146:15 pmRNSMigration of Shares
19th May 20147:00 amRNSVamousse product line available online across USA
30th Apr 20147:00 amRNSNatunex product launched across USA
24th Apr 20147:00 amRNSUSA Pest Control Patents Secured
8th Apr 20146:10 pmRNSDirector's Dealings
7th Apr 20144:41 pmRNSDirector's Dealings
1st Apr 20147:00 amRNSVamousse at over 4,000 Walmart Stores in USA
7th Mar 20147:00 amRNSMigration of Shares
6th Mar 201411:48 amRNSHolding(s) in Company
6th Mar 20147:00 amRNSAward of Share Options
24th Feb 20147:00 amRNSProposed Migration of Shares
18th Feb 20143:38 pmRNSResult of Special Meeting
13th Feb 20149:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.